Mayo Clinic Test Changes Care for Half of Lung Patients

A new genetic testing approach at Mayo Clinic is transforming how doctors diagnose and treat pulmonary fibrosis, changing treatment plans for more than half of patients studied.

The breakthrough combines telomere measurement with DNA testing to uncover hidden disease causes.